Donald Zurbay

LivaNova PLC is a global medical technology company built on 50+ years of experience and a Vision to change the trajectory of lives for a new day. Our Mission is to create ingenious medical solutions that ignite patient turnarounds. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the Nasdaq stock exchange under the ticker symbol “LIVN.” LivaNova has approximately 3,000 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. As a worldwide leader in cardiopulmonary and neuromodulation, we don’t just treat conditions—we aspire to alter the course of lives. So from patients seeking answers to impossible situations to clinicians striving to do their best work to employees finding a place where they can change the world— Welcome to LivaNova. Welcome to your new life.

We are transforming ophthalmology and optometry by addressing the underlying causes of two of the world’s most prevalent eye diseases, glaucoma and dry eye.

Avedro is a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Avedro’s proprietary Avedro Corneal Remodeling Platform strengthens, stabilizes and reshapes the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. The Avedro Corneal Remodeling Platform is comprised of Avedro’s KXL and Mosaic systems, each of which delivers ultraviolet A light, and a suite of proprietary single-use riboflavin drug formulations, which, when applied together to the cornea, induce a biochemical reaction called corneal collagen cross-linking.

A Global Total Solutions Provider Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. Our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. Dentsply Sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. As The Dental Solutions Company™ Dentsply Sirona’s comprehensive solutions offering includes leading product brands across consumables, equipment, technology and specialty products. With the broadest clinical education platform and an unparalleled commitment to R&D in dentistry, our mission and vision guide us to continuously aim higher, support our customers and advance patient care around the world. Dentsply Sirona’s Global Headquarters is located in Charlotte, North Carolina. Our shares are listed in the United States on NASDAQ under the symbol XRAY. We care about your privacy - you can view our Privacy Policy here: http://www.dentsplysirona.com/privacy.

LivaNova PLC is a global medical technology company built on 50+ years of experience and a Vision to change the trajectory of lives for a new day. Our Mission is to create ingenious medical solutions that ignite patient turnarounds. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the Nasdaq stock exchange under the ticker symbol “LIVN.” LivaNova has approximately 3,000 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. As a worldwide leader in cardiopulmonary and neuromodulation, we don’t just treat conditions—we aspire to alter the course of lives. So from patients seeking answers to impossible situations to clinicians striving to do their best work to employees finding a place where they can change the world— Welcome to LivaNova. Welcome to your new life.

We are transforming ophthalmology and optometry by addressing the underlying causes of two of the world’s most prevalent eye diseases, glaucoma and dry eye.

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on the company, visit our website at http://silkroadmed.com/. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention. For more information about the TCAR procedure and essential prescribing information, please visit http://silkroadmed.com/ifus/. For more information about carotid artery disease and the risks involved with any intervention (e.g. bleeding, death, myocardial infarction, restenosis, stroke, TIA, vessel dissection, vessel occlusion, etc.), please visit http://silkroadmed.com/disease-and-treatment-options/.

Avedro is a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses. Avedro’s proprietary Avedro Corneal Remodeling Platform strengthens, stabilizes and reshapes the cornea utilizing corneal cross-linking in minimally invasive and non-invasive outpatient procedures to treat corneal ectatic disorders and correct refractive conditions. The Avedro Corneal Remodeling Platform is comprised of Avedro’s KXL and Mosaic systems, each of which delivers ultraviolet A light, and a suite of proprietary single-use riboflavin drug formulations, which, when applied together to the cornea, induce a biochemical reaction called corneal collagen cross-linking.